216 related articles for article (PubMed ID: 11806791)
1. The role of dyslipidemia and statins in venous thromboembolism.
Ray JG; Rosendaal FR
Curr Control Trials Cardiovasc Med; 2001; 2(4):165-170. PubMed ID: 11806791
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia, statins, and venous thromboembolism.
Poredos P; Jezovnik MK
Semin Thromb Hemost; 2011 Nov; 37(8):897-902. PubMed ID: 22198854
[TBL] [Abstract][Full Text] [Related]
3. Statins and venous thromboembolism: do they represent a viable therapeutic agent?
Kunutsor SK; Whitehouse MR; Blom AW; Laukkanen JA
Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):629-637. PubMed ID: 28724320
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia, statins, and venous thromboembolism: a potential risk factor and a potential treatment.
Ray JG
Curr Opin Pulm Med; 2003 Sep; 9(5):378-84. PubMed ID: 12904707
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins in primary and secondary prevention for venous thromboembolism events: A meta analysis.
Zhu H; Zheng H; Xu T; Liu X; Liu X; Sun L; Pan XF; Mai W; Cai X; Huang Y
Vascul Pharmacol; 2022 Feb; 142():106931. PubMed ID: 34763100
[TBL] [Abstract][Full Text] [Related]
6. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C
Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Statins for Prevention of Venous Thromboembolism.
Chaffey P; Thompson M; Pai AD; Tafreshi AR; Tafreshi J; Pai RG
Am J Cardiol; 2018 Jun; 121(11):1436-1440. PubMed ID: 29576234
[TBL] [Abstract][Full Text] [Related]
8. Effect of statins on the risk of recurrent venous thromboembolism: A systematic review and meta-analysis.
Li R; Yuan M; Yu S; Fu W; Yu W; Ling S; Sun J; Chen Y
Pharmacol Res; 2021 Mar; 165():105413. PubMed ID: 33412275
[TBL] [Abstract][Full Text] [Related]
9. Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review.
Orsi FA; Cannegieter SC; Lijfering WM
Semin Thromb Hemost; 2019 Nov; 45(8):825-833. PubMed ID: 31096309
[TBL] [Abstract][Full Text] [Related]
10. [Statins can maybe reduce the risk of venous thromboembolism].
Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
[TBL] [Abstract][Full Text] [Related]
11. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
[TBL] [Abstract][Full Text] [Related]
12. Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
Skajaa N; Szépligeti SK; Horváth-Puhó E; Ghanima W; Hansen JB; Sørensen HT
Thromb Res; 2019 Dec; 184():99-104. PubMed ID: 31715545
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
Skajaa N; Nagy D; Troelsen FS; Farkas DK; Sørensen HT
Thromb Res; 2021 May; 201():1-5. PubMed ID: 33621859
[TBL] [Abstract][Full Text] [Related]
14. Statins for primary prevention of venous thromboembolism.
Li L; Sun T; Zhang P; Tian J; Yang K
Cochrane Database Syst Rev; 2011 Dec; (12):CD008203. PubMed ID: 22161421
[TBL] [Abstract][Full Text] [Related]
15. Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.
Birdal O; Saygı M; Doğan R; Tezen O; Karagöz A; Tanboğa İH
Balkan Med J; 2023 Sep; 40(5):324-332. PubMed ID: 37519020
[TBL] [Abstract][Full Text] [Related]
16. Statins for the prevention of venous thromboembolism? a narrative review.
Sehdev A; Wanner N; Pendleton RC
Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090
[TBL] [Abstract][Full Text] [Related]
17. Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
[TBL] [Abstract][Full Text] [Related]
18. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
20. [Drugs and venous thromboembolism].
Lacut K; Mottier D; Pottier P
Rev Pneumol Clin; 2008 Dec; 64(6):290-7. PubMed ID: 19084208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
